No. |
Classification |
Name of Lecture |
Study period |
Hours |
1 |
Online/Lecture |
[Lecture 1] U.S. Food and Drug Administration (FDA)’s Good Clinical Practice Assessment and Review for Marketing Applications |
2024-11-14 00:00 ~ 2024-12-01 00:00
|
40minute
|
2 |
Online/Lecture |
[Lecture 2] (MFDS) What Regulators/Inspectors Expect in GCP Inspection and Current Trends Based on Actual Experiences |
2024-11-14 00:00 ~ 2024-12-01 00:00
|
40minute
|
3 |
Online/Lecture |
[Lecture 3] (EMA) Draft ICH E6 (R3) Guideline - Regulatory Perspective |
2024-11-14 00:00 ~ 2024-12-01 00:00
|
40minute
|
4 |
Online/Lecture |
[Lecture 4] Putting principles into Practice: Implementing The Updated ICH E6 |
2024-11-14 00:00 ~ 2024-12-01 00:00
|
40minute
|
5 |
Online/Lecture |
[Lecture 5] Considerations on The Multi-Regional Decentralized Trials |
2024-11-14 00:00 ~ 2024-12-01 00:00
|
40minute
|
6 |
Online/Lecture |
[Lecture 6] Intelligent Multi-Regional Clinical Trials (MRCT) Strategy |
2024-11-14 00:00 ~ 2024-11-30 00:00
|
40minute
|